LifeStance Health Group, Inc. (LFST)
| Previous close | 5.71 |
| Open | 5.69 |
| Bid | 5.71 x 300 |
| Ask | 5.75 x 100 |
| Day's range | 5.69 - 5.84 |
| 52-week range | 4.74 - 9.59 |
| Volume | |
| Avg. volume | 1,345,780 |
| Market cap | 2.185B |
| Beta (5Y monthly) | 1.34 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.51 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.79 |
GlobeNewswireLifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its first quarter 2024 earnings release before the market opens on Thursday, May 9, 2024. LifeStance will host a live earnings conference call to discuss first quarter results on May 9, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internati
Simply Wall St.At US$6.13, Is It Time To Put LifeStance Health Group, Inc. (NASDAQ:LFST) On Your Watch List?
LifeStance Health Group, Inc. ( NASDAQ:LFST ), is not the largest company out there, but it received a lot of attention...
PR NewswireLifeStance Appoints Dr. Teresa DeLuca to Board of Directors
LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of dir
